Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

Is Tecta Still on Backorder in Canada? 2026 Shortage Status

Published September 16, 2026 · Updated October 11, 2026 · 4 min read · Shortage status updates automatically

Quick answer

Tecta (pantoprazole magnesium 40mg enteric-coated tablets, Takeda Canada, DIN 02267233) went on backorder twice in 2026 due to higher demand, and Takeda's latest report was marked resolved on October 6, 2026 — so as of mid-October 2026 it's no longer reported in shortage, though individual pharmacies may still be restocking. The live status above always shows the current report, and if it goes short again, ask your pharmacist about a different pantoprazole product before switching to a different PPI entirely — don't crush or split the tablets to stretch a limited supply.

What Tecta is

Tecta is the Canadian brand name for pantoprazole magnesium 40mg enteric-coated tablets, made by Takeda Canada Inc. — DIN 02267233. It's a proton pump inhibitor (PPI) used to treat GERD, erosive esophagitis, and, in combination with antibiotics, H. pylori infection. Most PPI brands sold in Canada use the pantoprazole sodium salt instead — Tecta is one of the few that uses the magnesium salt, which is why it isn't always a straightforward one-to-one swap with a generic pantoprazole product.

Check the current status, not a past report

Tecta was reported short twice in 2026 — a report resolved in June, then another resolved on October 6 — both times because of an increase in demand rather than a manufacturing problem. Demand-driven shortages like this can come back, so a "back in stock" headline doesn't stay accurate forever either. Check the current status for DIN 02267233 on MedShort rather than relying on a search result or forum post that may reflect an older report.

Don't crush or split the tablets to make a supply last longer

Tecta tablets are enteric-coated so the medication survives stomach acid before it dissolves further down the digestive tract. Crushing, splitting, or chewing a tablet to stretch a limited supply can destroy that coating and reduce how well the drug works, or make it harder on your stomach. If your pharmacy is low, contact your pharmacist as soon as you notice a supply problem rather than adjusting how you take it.

What a pharmacist can — and can't — do about it

Because Tecta uses the magnesium salt of pantoprazole rather than the more common sodium salt, switching to a different manufacturer's pantoprazole product isn't always treated as an automatic like-for-like substitution the way it would be between two sodium-salt generics — check with your pharmacist first. They may still be able to source Tecta from another pharmacy, or suggest a different PPI covered by your plan. See when a pharmacist can substitute during a shortage and when it needs your prescriber instead.

If it's the whole PPI class you're worried about

A shortage of one brand rarely means every PPI is unavailable — omeprazole, pantoprazole (sodium salt), and rabeprazole are each made by several generic manufacturers in Canada. See the full PPI shortage guide for what's usually still in stock.

Where to check

Search Tecta or DIN 02267233 on MedShort for the current status pulled directly from Health Canada's Drug Shortages Canada reporting system — the same source your pharmacy checks.

Related Guides

Latest Canadian Shortage Updates

FRESENIUS KABI CANADA LTD

10000UNIT · DIN 02264307

Resolved

Updated: 2026-11-12

FRESENIUS KABI CANADA LTD

1MG · DIN 02244622

Resolved

Updated: 2026-11-12

BGP PHARMA ULC

75MCG · DIN 02172089

Active Shortage

Updated: 2026-11-12

SANIS HEALTH INC

20MG · DIN 02284758

Active Shortage

Updated: 2026-11-11

Guide text last reviewed October 11, 2026; the shortage status shown above is pulled from Health Canada's data and refreshed hourly. MedShort.ca is an independent tracking tool and does not provide medical advice.